Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Urinary kidney injury molecule-1 is related to pathologic involvement in IgA nephropathy with normotension, normal renal function and mild proteinuria

Authors: Peng-cheng Xu, Li Wei, Wen-ya Shang, Shun-li Tian, Dong-mei Gu, Tie-kun Yan, Shan Lin

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

IgA nephropathy (IgAN) may progress to renal failure for some patients without any clinical risk factors and it is not unusual to find severe pathologic damage in clinically mild IgAN. We therefore investigated whether urinary kidney injury molecule-1 (KIM-1) was related to pathologic involvement in clinically mild IgAN.

Methods

Urinary KIM-1/creatinine of 51 IgAN patients with normotension, normal renal function and proteinuria < 1.0 g/24 h were tested. Relationships between urinary KIM-1 and pathologic features were analyzed.

Results

Eighteen of the 51 patients had elevated urinary KIM-1. The tubular atrophy/interstitial fibrosis was more severe in patients with elevated urinary KIM-1 than that in patients with normal urinary KIM-1 (T0/T1/T2, 13/5/0 vs. 33/0/0, P = 0.004). Proportion of glomeruli containing cresecents was higher in patients with elevated urinary KIM-1 than that in patients with normal urinary KIM-1 (50% vs. 18%, P = 0.026). Urinary KIM-1 correlated with the proportion of total crescents (R = 0.303, p = 0.031) and fibrous crescents (R = 0.456, p = 0.001), but did not correlate with the proportion of cellular crescents or fibrocellular crescents. Although the proportion of vascular lesions was higher in patients with elevated urinary KIM-1 (44.4%) than that in patients with normal urinary KIM-1 (18.1%), the difference was not significant (p = 0.057). There was no difference of the response to treatment between patients with and without elevated urinary KIM-1 during a short-term follow-up.

Conclusions

Urinary KIM-1 is a reflection of tubularinstitial injury. For patients with clinically mild IgAN, high urinary KIM-1 is related to relatively severe pathologic involvement on renal biopsy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y: A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant. 2009, 24: 3068-3074.CrossRefPubMedPubMedCentral Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y: A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant. 2009, 24: 3068-3074.CrossRefPubMedPubMedCentral
3.
go back to reference Reich HN, Troyanov S, Scholey JW, Cattran DC: Toronto Glomerulonephritis Registry: Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007, 18: 3177-3183.CrossRefPubMed Reich HN, Troyanov S, Scholey JW, Cattran DC: Toronto Glomerulonephritis Registry: Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007, 18: 3177-3183.CrossRefPubMed
4.
go back to reference Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM: Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant. 2002, 17: 1197-1203.CrossRefPubMed Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM: Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant. 2002, 17: 1197-1203.CrossRefPubMed
5.
go back to reference Bartosik LP, Lajoie G, Sugar L, Cattran DC: Predicting progression in IgA nephropathy. Am J Kidney Dis. 2001, 38: 728-735.CrossRefPubMed Bartosik LP, Lajoie G, Sugar L, Cattran DC: Predicting progression in IgA nephropathy. Am J Kidney Dis. 2001, 38: 728-735.CrossRefPubMed
6.
go back to reference Barbour SJ, Reich HN: Risk stratification of patients with IgA nephropathy. Am J Kidney Dis. 2012, 59: 865-873.CrossRefPubMed Barbour SJ, Reich HN: Risk stratification of patients with IgA nephropathy. Am J Kidney Dis. 2012, 59: 865-873.CrossRefPubMed
7.
go back to reference Li PK, Ho KK, Szeto CC, Yu L, Lai FM: Prognostic indicators of IgA nephropathy in the Chinese–clinical and pathological perspectives. Nephrol Dial Transplant. 2002, 17: 64-69.CrossRefPubMed Li PK, Ho KK, Szeto CC, Yu L, Lai FM: Prognostic indicators of IgA nephropathy in the Chinese–clinical and pathological perspectives. Nephrol Dial Transplant. 2002, 17: 64-69.CrossRefPubMed
8.
go back to reference Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK: The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med. 2001, 110: 434-437.CrossRefPubMed Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK: The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Am J Med. 2001, 110: 434-437.CrossRefPubMed
9.
go back to reference Schena FP: Immunoglobulin a nephropathy with mild renal lesions: a call in the forest for physicians and nephrologists. Am J Med. 2001, 110: 499-500.CrossRefPubMed Schena FP: Immunoglobulin a nephropathy with mild renal lesions: a call in the forest for physicians and nephrologists. Am J Med. 2001, 110: 499-500.CrossRefPubMed
10.
go back to reference Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C: The use of the Oxford classification of IgA nephropathy to predict renal survival. Clin J Am Soc Nephrol. 2011, 6: 2384-2388.CrossRefPubMedPubMedCentral Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C: The use of the Oxford classification of IgA nephropathy to predict renal survival. Clin J Am Soc Nephrol. 2011, 6: 2384-2388.CrossRefPubMedPubMedCentral
11.
go back to reference Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, Cattran DC: Validation of the Oxford classification of IgA nephropathy. Kidney Int. 2011, 80: 310-317.CrossRefPubMed Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, Cattran DC: Validation of the Oxford classification of IgA nephropathy. Kidney Int. 2011, 80: 310-317.CrossRefPubMed
12.
go back to reference Le W, Zeng CH, Liu Z, Liu D, Yang Q, Lin RX, Xia ZK, Fan ZM, Zhu G, Wu Y, Xu H, Zhai Y, Ding Y, Yang X, Liang S, Chen H, Xu F, Huang Q, Shen H, Wang J, Fogo AB, Liu ZH: Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. BMC Nephrol. 2012, 13: 158-CrossRefPubMedPubMedCentral Le W, Zeng CH, Liu Z, Liu D, Yang Q, Lin RX, Xia ZK, Fan ZM, Zhu G, Wu Y, Xu H, Zhai Y, Ding Y, Yang X, Liang S, Chen H, Xu F, Huang Q, Shen H, Wang J, Fogo AB, Liu ZH: Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. BMC Nephrol. 2012, 13: 158-CrossRefPubMedPubMedCentral
13.
go back to reference Shi SF, Wang SX, Jiang L, Lv JC, Liu LJ, Chen YQ, Zhu SN, Liu G, Zou WZ, Zhang H, Wang HY: Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrol. 2011, 6: 2175-2184.CrossRefPubMedPubMedCentral Shi SF, Wang SX, Jiang L, Lv JC, Liu LJ, Chen YQ, Zhu SN, Liu G, Zou WZ, Zhang H, Wang HY: Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrol. 2011, 6: 2175-2184.CrossRefPubMedPubMedCentral
14.
go back to reference Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV: Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest. 2008, 118: 1657-1668.CrossRefPubMedPubMedCentral Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV: Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest. 2008, 118: 1657-1668.CrossRefPubMedPubMedCentral
15.
go back to reference Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV: Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol. 2004, 286: F552-F563.CrossRefPubMed Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV: Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol. 2004, 286: F552-F563.CrossRefPubMed
16.
go back to reference Seo MS, Park MY, Choi SJ, Jeon JS, Noh H, Kim JK, Han DC, Hwang SD, Jin SY, Kwon SH: Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy. BMC Nephrol. 2013, 14: 139-CrossRefPubMedPubMedCentral Seo MS, Park MY, Choi SJ, Jeon JS, Noh H, Kim JK, Han DC, Hwang SD, Jin SY, Kwon SH: Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy. BMC Nephrol. 2013, 14: 139-CrossRefPubMedPubMedCentral
17.
go back to reference Kwon SH, Park MY, Jeon JS, Noh H, Choi SJ, Kim JK, Hwang SD, Jin SY, Han DC: KIM-1 expression predicts renal outcomes in IgA nephropathy. Clin Exp Nephrol. 2013, 17: 359-364.CrossRefPubMed Kwon SH, Park MY, Jeon JS, Noh H, Choi SJ, Kim JK, Hwang SD, Jin SY, Han DC: KIM-1 expression predicts renal outcomes in IgA nephropathy. Clin Exp Nephrol. 2013, 17: 359-364.CrossRefPubMed
18.
go back to reference Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, Van Goor H, Wetzels JF: High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrol Dial Transplant. 2011, 26: 3581-3588.CrossRefPubMed Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, Van Goor H, Wetzels JF: High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrol Dial Transplant. 2011, 26: 3581-3588.CrossRefPubMed
19.
go back to reference Xu PC, Zhang JJ, Chen M, Lv JC, Liu G, Zou WZ, Zhang H, Zhao MH: Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity. Nephrol Dial Transplant. 2011, 26: 3229-3236.CrossRefPubMed Xu PC, Zhang JJ, Chen M, Lv JC, Liu G, Zou WZ, Zhang H, Zhao MH: Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity. Nephrol Dial Transplant. 2011, 26: 3229-3236.CrossRefPubMed
20.
go back to reference Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006, 17: 2937-2944.CrossRefPubMed Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006, 17: 2937-2944.CrossRefPubMed
21.
go back to reference Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D’Agati V, D’Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, et al: The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009, 76: 534-545.CrossRefPubMed Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D’Agati V, D’Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, et al: The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009, 76: 534-545.CrossRefPubMed
22.
go back to reference Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D’Agati V, D’Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, et al: The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009, 76: 546-556.CrossRefPubMed Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D’Agati V, D’Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, et al: The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009, 76: 546-556.CrossRefPubMed
23.
go back to reference Van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, Van Goor H, Stegeman CA: Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007, 212: 209-217.CrossRefPubMed Van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, Van Goor H, Stegeman CA: Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007, 212: 209-217.CrossRefPubMed
24.
go back to reference Bitencourt-Dias C, Bahiense-Oliveira M, Saldanha LB, Barros RT, Woronik V: Comparative study of IgA nephropathy with and without crescents. Braz J Med Biol Res. 2004, 37: 1373-1377.CrossRefPubMed Bitencourt-Dias C, Bahiense-Oliveira M, Saldanha LB, Barros RT, Woronik V: Comparative study of IgA nephropathy with and without crescents. Braz J Med Biol Res. 2004, 37: 1373-1377.CrossRefPubMed
25.
go back to reference Lv J, Yang Y, Zhang H, Chen W, Pan X, Guo Z, Wang C, Li S, Zhang J, Zhang J, Liu L, Shi S, Wang S, Chen M, Cui Z, Chen N, Yu X, Zhao M, Wang H: Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study. J Am Soc Nephrol. 2013, 24: 2118-2125.CrossRefPubMedPubMedCentral Lv J, Yang Y, Zhang H, Chen W, Pan X, Guo Z, Wang C, Li S, Zhang J, Zhang J, Liu L, Shi S, Wang S, Chen M, Cui Z, Chen N, Yu X, Zhao M, Wang H: Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study. J Am Soc Nephrol. 2013, 24: 2118-2125.CrossRefPubMedPubMedCentral
26.
go back to reference Tang Z, Wu Y, Wang QW, Yu YS, Hu WX, Yao XD, Chen HP, Liu ZH, Li LS: Idiopathic IgA nephropathy with diffuse crescent formation. Am J Nephrol. 2002, 22: 480-486.CrossRefPubMed Tang Z, Wu Y, Wang QW, Yu YS, Hu WX, Yao XD, Chen HP, Liu ZH, Li LS: Idiopathic IgA nephropathy with diffuse crescent formation. Am J Nephrol. 2002, 22: 480-486.CrossRefPubMed
27.
go back to reference Feiner HD, Cabili S, Baldwin DS, Schacht RG, Gallo GR: Intrarenal vascular sclerosis in IgA nephropathy. Clin Nephrol. 1982, 18: 183-192.PubMed Feiner HD, Cabili S, Baldwin DS, Schacht RG, Gallo GR: Intrarenal vascular sclerosis in IgA nephropathy. Clin Nephrol. 1982, 18: 183-192.PubMed
28.
go back to reference Wu J, Chen X, Xie Y, Yamanaka N, Shi S, Wu D, Liu S, Cai G: Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant. 2005, 20: 719-727.CrossRefPubMed Wu J, Chen X, Xie Y, Yamanaka N, Shi S, Wu D, Liu S, Cai G: Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant. 2005, 20: 719-727.CrossRefPubMed
Metadata
Title
Urinary kidney injury molecule-1 is related to pathologic involvement in IgA nephropathy with normotension, normal renal function and mild proteinuria
Authors
Peng-cheng Xu
Li Wei
Wen-ya Shang
Shun-li Tian
Dong-mei Gu
Tie-kun Yan
Shan Lin
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-107

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.